Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 14, 2026
Why Is Merlin, Inc. (MRLN) Stock Down -16.74% Today?

Why Is Merlin, Inc. (MRLN) Stock Down -16.74% Today?

Key Takeaways

  • Shares of MRLN fell 16.74% to $3.68 in Friday morning trading, down $0.74 from Thursday's close of $4.42.
  • The primary catalyst was a second-quarter earnings miss: a net loss of $1.11 per share versus a consensus loss of $0.18, and revenue of $2.19 million versus roughly $3.85 million expected.
  • Cantor Fitzgerald added to the selling pressure by lowering its price target on MRLN to $9.00 from $11.00.
  • Adjusted EBITDA losses widened sequentially to $27.8 million, even as revenue improved from the first quarter.
  • Broader U.S. equity benchmarks were little changed at the open, underscoring that this was a company-specific move.
  • Traders are watching for further analyst revisions and execution on defense and commercial aviation programs.

Opening Summary

Merlin, Inc. (MRLN) is a Boston-based developer of AI-powered, takeoff-to-touchdown autonomous flight software for military and civil aircraft. Shares plunged 16.74% on Friday, changing hands at $3.68 after closing at $4.42 in the prior session. The selloff followed the company's second-quarter earnings release after Thursday's close, which missed both revenue and earnings expectations and prompted an analyst price-target reduction.

Earnings Results and Guidance

The company reported second-quarter revenue of $2.19 million, up from $1.0 million in the first quarter but below the roughly $3.85 million consensus and below year-earlier revenue of $3.1 million. It posted a net loss of $1.11 per share, far wider than the $0.18 per-share loss analysts expected. Adjusted EBITDA losses widened to $27.8 million from $23.3 million in the first quarter, reflecting heavy investment in engineering, certification activities, and program execution.

On a GAAP basis, the net loss narrowed to $58.4 million from $90.4 million in the prior quarter, helped by non-cash items tied to warrants and convertible promissory notes. Management highlighted milestones, including completion of the C-130J critical design review, an expanded commercial collaboration with Israel Aerospace Industries, and a Stage of Involvement 3 verification achievement. However, investors focused on the size of the earnings miss and rising operating losses. The company ended the quarter with $183.9 million in cash, cash equivalents, and short-term investments, and no debt.

Analyst Reaction

Cantor Fitzgerald added to the pressure on Friday by lowering its price target on MRLN to $9.00 from $11.00. The adjustment signaled that, while the firm maintained a constructive longer-term view, the latest quarter reset near-term expectations. The stock had already slipped in after-hours and pre-market trading, and the target cut reinforced the negative tone as the regular session opened.

Market Context and Trading Activity

Shares gapped lower at the open to $3.68, below overnight indications in the low-$4 area, and traded in a narrow early range of $3.66 to $3.70. The decline unwound Thursday's 6.25% pre-earnings gain and left the stock below its 50-day moving average near $5.03 and its 200-day moving average near $8.88. Turnover was heavy in the opening minutes as sellers digested the results. Broader U.S. equity benchmarks were roughly flat Friday morning, confirming that the move was driven by company-specific news rather than sector or macroeconomic pressure.

What Comes Next for MRLN

Investors will be watching whether additional analysts revise estimates or price targets following the earnings miss. Key milestones include further execution under the $105 million USSOCOM IDIQ contract, commercial collaborations such as the Israel Aerospace Industries partnership, and certification progress on the company's autonomous flight platform. The main risks are continued adjusted EBITDA losses, milestone-dependent defense revenue, small-cap volatility, and potential dilution from outstanding warrants and convertible instruments. With $183.9 million in cash and no debt, the company has runway to invest, but the path to narrower losses is now a central focus for the market.

Trending AI Robots

Tickeron's Trending AI Robots page features a curated selection of AI-powered trading bots. Tickeron offers hundreds of bots covering thousands of tickers, but only the strongest performers under current market conditions are highlighted in this section. Bots vary by strategy, timeframe, performance metrics, and traded symbols. Traders seeking systematic, data-driven approaches may find the section a useful starting point for monitoring market momentum.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MRLN

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


MRLN's RSI Oscillator recovers from oversold territory

The RSI Oscillator for MRLN moved out of oversold territory on July 23, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 5 similar instances when the indicator left oversold territory. In of the 5 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on MRLN as a result. In of 38 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MRLN just turned positive on July 23, 2026. Looking at past instances where MRLN's MACD turned positive, the stock continued to rise in of 13 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MRLN advanced for three days, in of 79 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRLN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MRLN broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MRLN entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (10.057). P/E Ratio (0.000) is within average values for comparable stocks, (64.691). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.160). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (46.296) is also within normal values, averaging (21.990).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MRLN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRLN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 43.01B. The market cap for tickers in the group ranges from 4.49 to 1.86T. SPCX holds the highest valuation in this group at 1.86T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was 4%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 6%. DFSC experienced the highest price growth at 88%, while EVTL experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was 92% and the average quarterly volume growth was 109%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 66
Price Growth Rating: 51
SMR Rating: 78
Profit Risk Rating: 71
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
MRLN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of equipment leasing solutions to small businesses

Industry AerospaceDefense

Profile
Details
Industry
Finance Or Rental Or Leasing
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.